Penetration of clarithromycin into human saliva. 1993

J Wüst, and U Hardegger
Department of Medical Microbiology, University of Zurich, Switzerland.

The concentrations of clarithromycin after a single oral dose of 500 mg were determined in serum and saliva of ten healthy adult volunteers. After 2 h, the levels were 4.04 +/- 1.14 (SD) mg/l in serum and 2.72 +/- 0.87 mg/l in saliva. After 7 h these values were 1.98 +/- 0.65 and 1.21 +/- 0.34 mg/l, respectively, and at the end of the dosing interval of 12 h, 0.95 +/- 0.38 and 0.73 +/- 0.35 mg/l, respectively. In comparison, amoxicillin (a 750-mg single dose) showed a much faster decline of serum levels and was virtually undetectable in saliva.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000658 Amoxicillin A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. Hydroxyampicillin,Actimoxi,Amoxicillin Anhydrous,Amoxicillin Monopotassium Salt,Amoxicillin Monosodium Salt,Amoxicillin Sodium,Amoxicillin Trihydrate,Amoxicillin, (R*)-Isomer,Amoxicilline,Amoxil,Amoxycillin,BRL-2333,Clamoxyl,Clamoxyl G.A.,Clamoxyl Parenteral,Penamox,Polymox,Trimox,Wymox,BRL 2333,BRL2333
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D017291 Clarithromycin A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation. 6-O-Methylerythromycin,A-56268,Biaxin,TE-031,A 56268,A56268,TE 031,TE031

Related Publications

J Wüst, and U Hardegger
December 1993, Antimicrobial agents and chemotherapy,
J Wüst, and U Hardegger
April 1989, The Japanese journal of antibiotics,
J Wüst, and U Hardegger
April 1994, Antimicrobial agents and chemotherapy,
J Wüst, and U Hardegger
January 2018, The European respiratory journal,
J Wüst, and U Hardegger
July 1987, Arzneimittel-Forschung,
J Wüst, and U Hardegger
April 1963, Casopis lekaru ceskych,
J Wüst, and U Hardegger
September 1981, British journal of clinical pharmacology,
J Wüst, and U Hardegger
January 1997, The Pediatric infectious disease journal,
J Wüst, and U Hardegger
September 1993, Journal of endodontics,
J Wüst, and U Hardegger
January 2013, Current pharmaceutical design,
Copied contents to your clipboard!